| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) | 
|---|
| 10/26/2010 | US7820619 potentiate antimicrobial functions of leukocytes such as neutrophils; lower inherent mammalian cell toxicities, improved immunogenicity and shortness of duration of effectiveness due to biodegradation, retaining activity in plasma and serum; antibiotic resistance; pharmacokinetics | 
| 10/26/2010 | US7820400 Tumor-associated marker | 
| 10/26/2010 | US7820390 Methods of and kits and compositions for diagnosing colorectal tumors | 
| 10/26/2010 | CA2133323C Self-assembling polynucleotide delivery system | 
| 10/21/2010 | WO2010121023A2 Peptides and aptamers for targeting of neuron or nerves | 
| 10/21/2010 | WO2010121013A2 Molecularly imprinted polymers for detecting hiv-1 | 
| 10/21/2010 | WO2010119583A1 Polymer-nucleic acid complex, method for imaging tumor cells or the like using same, and pharmaceutical composition for treatment of cancer | 
| 10/21/2010 | WO2010119192A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate | 
| 10/21/2010 | WO2010119191A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function | 
| 10/21/2010 | WO2010118547A1 Protein for the immunocastration for mammals | 
| 10/21/2010 | WO2010118521A1 Peptide ligands for clusterin and uses thereof | 
| 10/21/2010 | WO2010099472A3 Spanx-b polypeptides and their use | 
| 10/21/2010 | WO2010065815A3 Mini-hepcidin peptides and methods of using thereof | 
| 10/21/2010 | WO2009111273A3 Peptide targeting imaging agents and methods of use thereof | 
| 10/21/2010 | US20100267928 Activatable diagnostic and therapeutic compound | 
| 10/21/2010 | US20100267927 Structure of the Insulin Receptor Ectodomain | 
| 10/21/2010 | US20100267651 T cell antigen receptor peptides | 
| 10/21/2010 | US20100267650 Dual Chain Synthetic Heparin-Binding Growth Factor Analogs | 
| 10/21/2010 | US20100267628 Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of Diabetes | 
| 10/21/2010 | US20100267623 Peptides with capacity to bind to scurfin and applications | 
| 10/21/2010 | US20100267621 Antimicrobial Compounds and Formulations | 
| 10/21/2010 | US20100267608 Modifications of cupredoxin derived peptides and methods of use thereof | 
| 10/21/2010 | US20100267019 Identification And Use Of Genes Encoding Amatoxin And Phallotoxin | 
| 10/21/2010 | US20100267005 Crosslinking Within Coordination Complexes | 
| 10/21/2010 | US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases | 
| 10/21/2010 | US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 | 
| 10/21/2010 | US20100266557 Novel peptide-based scaffolds for cartilage regeneration and methods for their use | 
| 10/21/2010 | US20100266508 Stabilized gold nanoparticle and contrast agent | 
| 10/21/2010 | CA2756570A1 Peptide ligands for clusterin and uses thereof | 
| 10/21/2010 | CA2669470A1 Assay for detecting cathepsin k activity in bone, cartilage and/or soft tissue | 
| 10/20/2010 | EP2241573A2 Peptide derivatives and cosmetic composition comprising the same | 
| 10/20/2010 | EP2240770A1 Methods for detection of cyclosporin a | 
| 10/20/2010 | EP2240604A2 Peptides and methods of use as therapeutics and screening agents | 
| 10/20/2010 | EP2240507A2 Processes for preparing high purity aza cyclohexapeptides | 
| 10/20/2010 | EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins | 
| 10/20/2010 | CN101863971A Metastin derivatives and use thereof | 
| 10/20/2010 | CN101863965A Helicobacter pylori urease B antigenic epitope polypeptide and application thereof | 
| 10/20/2010 | CN101863964A Helicobacter pylori urease B antigen epitope polypeptide and application thereof | 
| 10/20/2010 | CN101863963A Helicobacter pylori antigen epitope polypeptide and application thereof | 
| 10/20/2010 | CN101863962A Polypeptide for inhibiting enzyme digestion of beta secretase and application thereof | 
| 10/20/2010 | CN101863961A Preparation method of octreotide | 
| 10/20/2010 | CN101863960A Preparation method of cetrorelix | 
| 10/20/2010 | CN101863958A Induction of the mitochondrial permeability transition | 
| 10/20/2010 | CN101225106B Short peptide suppressing growth of cancer cell and uses thereof | 
| 10/19/2010 | US7816490 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT | 
| 10/19/2010 | US7816489 Methods for making intermediates and oxytocin analogues | 
| 10/19/2010 | US7816325 secondary binding site of dipeptidyl peptidase IV, its relationship amongst substrates and to the modulation of substrate specificity of dipeptidyl peptidase IV (DP IV, synonym: DPP IV, CD26, EC 3.4.14.5). The application relates further to compounds that bind to the secondary binding site of DP IV | 
| 10/19/2010 | CA2437081C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue | 
| 10/19/2010 | CA2334914C Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof | 
| 10/19/2010 | CA2193130C New streptogramins and process for preparing streptogramins by mutasynthesis | 
| 10/19/2010 | CA2147499C Prostate-specific membrane antigen | 
| 10/14/2010 | WO2010117997A2 Peptide targeting of inner ear cells | 
| 10/14/2010 | WO2010117753A2 Peptide compositions for oral care systems | 
| 10/14/2010 | WO2010117079A1 Neuronal differentiation-inducing peptide and use thereof | 
| 10/14/2010 | WO2010117078A1 Neuronal differentiation-inducing peptide and use thereof | 
| 10/14/2010 | WO2010117055A1 Polypeptide having selective inhibitory activity on protein kinase cα or η | 
| 10/14/2010 | WO2010116752A1 Neuromedin u derivative | 
| 10/14/2010 | WO2010115916A1 Process for isolating therapeutic peptide | 
| 10/14/2010 | WO2010074433A3 Novel bacteriophage and antibacterial composition comprising same | 
| 10/14/2010 | WO2010042548A9 Methods of treating inflammation | 
| 10/14/2010 | US20100261877 Process for isolating therapeutic peptides | 
| 10/14/2010 | US20100261876 Novel methods of synthesis for therapeutic antiviral peptides | 
| 10/14/2010 | US20100261875 Peptides that specifically bind HGF receptor (CMET) and uses thereof | 
| 10/14/2010 | US20100261658 Peptide for activating aquaporin synthesis | 
| 10/14/2010 | US20100261650 Recombinant fusion proteins to growth hormone and serum albumin | 
| 10/14/2010 | US20100261638 Lantibiotic-based compounds having antimicrobial activity | 
| 10/14/2010 | US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods | 
| 10/14/2010 | US20100261206 Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof | 
| 10/14/2010 | US20100260817 Polyamine Derivatives | 
| 10/14/2010 | US20100260791 Chlamydia antigens | 
| 10/14/2010 | US20100260790 S. Pneumoniae Antigens | 
| 10/14/2010 | US20100260752 Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria | 
| 10/14/2010 | US20100260673 Phage display peptide probes for imaging early responses to antiangiogenic treatment | 
| 10/14/2010 | US20100260672 Peptides that specifically bind hgf receptor (cmet) and uses thereof | 
| 10/14/2010 | CA2758264A1 Neuromedin u derivative | 
| 10/13/2010 | EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction | 
| 10/13/2010 | EP2239267A1 Tag peptide and use thereof | 
| 10/13/2010 | CN101861334A Cyclic receptor-associated protein (RAP) peptides | 
| 10/13/2010 | CN101861330A Polypeptide compound | 
| 10/13/2010 | CN101861329A Peptides as antimicrobial agents towards campylobacter spp | 
| 10/13/2010 | CN101861160A Antagonists of kisspeptin and uses thereof | 
| 10/13/2010 | CN101857632A Preparation and use of fatty acyl glycyl glycyl histidine-copper (II) complexes | 
| 10/13/2010 | CN101857631A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | 
| 10/13/2010 | CN101857630A Fluorouracil derivative containing tyrosine-isoleucine-glycine-serine-arginine polypeptide | 
| 10/13/2010 | CN101857629A Solid-phase synthesis method of Bremelanotide | 
| 10/13/2010 | CN101190939B Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application | 
| 10/12/2010 | US7812118 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) | 
| 10/12/2010 | US7811995 Therapeutic and diagnostic peptides | 
| 10/12/2010 | US7811993 BRAFV600E-based peptide mutants that induce major histocompatibility complex (MHC) Class I-dependent cytotoxic T cell responses provide prophylactic, diagnosis and therapeutic treatments; anticarcinogenic agents; drug development for non-peptide mimetics and in development of antibodies, vaccines | 
| 10/12/2010 | US7811992 Measuring binding of Bradykinin and angiogensin receptor; calibration; animal hibernation | 
| 10/12/2010 | US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents | 
| 10/12/2010 | US7811828 Method for identifying and quantifying of tumuor-associated | 
| 10/12/2010 | US7811551 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma | 
| 10/12/2010 | CA2497287C Method of humanizing immune system molecules | 
| 10/07/2010 | WO2010115080A2 Self-assembling peptides bearing organic electronic functionality and applications employing the same | 
| 10/07/2010 | WO2010115052A2 Induced pluripotent stem cells | 
| 10/07/2010 | WO2010114185A1 Method for preparing dendritic cells with capacity to induce cancer-specific immune response, and pharmaceutical composition and kit incorporating dendritic cells for preventing or treating cancer or inhibiting metastasis | 
| 10/07/2010 | WO2010113753A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide | 
| 10/07/2010 | WO2010113495A1 C6orf167 peptides and vaccines containing the same | 
| 10/07/2010 | WO2010113042A1 Antimicrobial cyclic peptides |